Filing search / Immunocore Holdings plc / "Healthcare"

10-Q

2024 Q1

IMCR Immunocore Holdings plc

8 May 24

Quarterly report

7:00am

significant market acceptance among physicians, patients and healthcare payors; our ability to maintain regulatory approval of KIMMTRAK for metastatic … countries, including potential changes in healthcare laws and regulations; our financial performance and our ability to effectively manage our anticipated

DEF 14A

IMCR Immunocore Holdings plc

12 Apr 24

Definitive proxy

4:20pm

believe his extensive scientific background and experience in the healthcare industry qualify him to serve on our board of directors. Vote Required … previously served as a senior advisor to the Healthcare Businesswomen’s Association and a Member of the Biotechnology Industry Organization Board. Ms

424B7

IMCR Immunocore Holdings plc

5 Apr 24

Prospectus with selling stockholder info

4:34pm

ability to continue to generate revenues, which is dependent upon maintaining significant market acceptance among physicians, patients and healthcare … and other countries, including potential changes in healthcare laws and regulations; our financial performance and our ability to effectively manage

PRE 14A

IMCR Immunocore Holdings plc

2 Apr 24

Preliminary proxy

4:45pm

sciences industry. We believe his extensive scientific background and experience in the healthcare industry qualify him to serve on our board of directors … . Additionally, she previously served as a senior advisor to the Healthcare Businesswomen’s Association and a Member of the Biotechnology Industry

S-3ASR

bp8aiomxydlt2y15 cm

20 Mar 24

Automatic shelf registration

8:51pm

10-K

0g21d0sc1rj5f 9lx6l1

28 Feb 24

Annual report

7:33am

8-K

vbp8pnv

5 Jan 24

Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation

7:19am

8-K

EX-99.1

mvzuahogh9suwzj h7w

5 Jan 24

Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation

7:19am

6-K

EX-99.2

hv58zn4 6i

7 Nov 23

Current report (foreign)

7:09am

6-K

EX-99.2

1da0an 0sjv9r

10 Aug 23

Current report (foreign)

8:28am

6-K

EX-99.3

sbjfh

10 May 23

Current report (foreign)

7:27am

6-K

EX-99.2

d8fdl5y8yukb792d

10 May 23

Current report (foreign)

7:27am

6-K

EX-99.1

jmpc3zyq81g37r sspe

18 Apr 23

Current report (foreign)

4:13pm

6-K/A

EX-99.1

m69rv 212

18 Nov 22

Index to Unaudited Condensed Consolidated Interim Financial Statements

4:17pm

6-K

EX-99.4

bw4dp8n 1oilsoriec

9 Nov 22

Index to Unaudited Condensed Consolidated Interim Financial Statements

7:15am

6-K

EX-99.2

gpov ykssz69yjvf

9 Nov 22

Index to Unaudited Condensed Consolidated Interim Financial Statements

7:15am

6-K

EX-99.1

jqgfntt7c7a

9 Nov 22

Index to Unaudited Condensed Consolidated Interim Financial Statements

7:15am

424B7

eig1k 1myb0ri

30 Sep 22

Prospectus with selling stockholder info

4:15pm

424B5

r9xsasw w7extp

9 Sep 22

Prospectus supplement for primary offering

4:23pm